ROS-induced toxicity: exposure of 3T3, RAW264.7, and MCF7 cells to superparamagnetic iron oxide nanoparticles results in cell death by mitochondria-dependent apoptosis
Source abstract
Abstract
Superparamagnetic nanoparticles (Fe3O4, SPIO) have been used as magnetic resonance imaging enhancers for years. However, bio-safety issues concerning nanoparticles remain largely unexplored. Of particular concern is the possible cellular impact of nanoparticles during SPIO uptake and subsequent oxidative stress. SPIO causes cell death by apoptosis via a little understood mitochondrial pathway. To more closely examine this process, three kinds of cells—3T3, RAW264.7, and MCF7—were treated with SPIO coated with polyethylene glycol (SPIO-PEG) and monitored by transmission electron microscopy (TEM), using cytotoxicity evaluation, mitochondrial activity, reactive oxygen species (ROS) generation, and Annexin V assay. TEM revealed that SPIO-PEG nanoparticles surrounded the cellular endosome membrane, creating a bulge in the endosome. Compared to 3T3 cells, greater numbers of SPIO-PEG nanoparticles infiltrated the mitochondria of RAW264.7 and MCF7 cells. SPIO-PEG residency is associated with boosted ROS, with elevated levels of mitochondrial activity, and advancement of cell apoptosis. Furthermore, correlation analysis showed that a polynomial model demonstrates a better fit than a linear model in MCF7, implying that cytotoxicity may have alternative impacts on cell death at different concentrations. Thus, we believe that MCF7 cell death results from the apoptosis pathway triggered by mitochondria, and we find lower cytotoxicity in 3T3. We propose that optimal levels of SPIO-PEG nanoparticles lead to increased levels of ROS and a resulting oxidative stress environment which will kill only cancer cells while sparing normal cells. This finding has great potential for use in cancer therapies in the future.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoparticles: synthesis and applications · Trace Elements in Health
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (41)
Show source-provided references
1. Amstad E, Zurcher S, Mashaghi A, Wong JY, Textor M, Reimhult E (2009) Surface functionalization of single superparamagnetic iron oxide nanoparticles for targeted magnetic resonance imaging. Small 5:1334–1342. doi: 10.1002/smll.20080132810.1002/smll.200801328 ↗
2. Chen CL et al (2011) A new nano-sized iron oxide particle with high sensitivity for cellular magnetic resonance imaging. Mol Imaging Biol 13:825–839. doi: 10.1007/s11307-010-0430-x10.1007/s11307-010-0430-x ↗
3. Chen ZW et al (2012) Dual enzyme-like activities of iron oxide nanoparticles and their implication for diminishing cytotoxicity. ACS Nano 6:4001–4012. doi: 10.1021/nn300291r10.1021/nn300291r ↗
4. Cho WS et al (2009) Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 236:16–24. doi: 10.1016/j.taap.2008.12.02310.1016/j.taap.2008.12.023 ↗
5. Colombo M et al (2012) Biological applications of magnetic nanoparticles. Chem Soc Rev 41:4306–4334. doi: 10.1039/c2cs15337h10.1039/c2cs15337h ↗
6. Diaz B et al (2008) Assessing methods for blood cell cytotoxic responses to inorganic nanoparticles and nanoparticle aggregates. Small 4:2025–2034. doi: 10.1002/smll.20080019910.1002/smll.200800199 ↗
7. Durazo SA, Kompella UB (2012) Functionalized nanosystems for targeted mitochondrial delivery. Mitochondrion 12:190–201. doi: 10.1016/j.mito.2011.11.00110.1016/j.mito.2011.11.001 ↗
8. Hervouet E, Simonnet H, Godinot C (2007) Mitochondria and reactive oxygen species in renal cancer. Biochimie 89:1080–1088. doi: 10.1016/j.biochi.2007.03.01010.1016/j.biochi.2007.03.010 ↗
9. Huang D-M et al (2009) The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles. Biomaterials 30:3645–3651. doi: 10.1016/j.biomaterials.2009.03.03210.1016/j.biomaterials.2009.03.032 ↗
10. Huang JG, Leshuk T, Gu FX (2011) Emerging nanomaterials for targeting subcellular organelles. Nano Today 6:478–492. doi: 10.1016/j.nantod.2011.08.00210.1016/j.nantod.2011.08.002 ↗
11. Irfan A, Cauchi M, Edmands W, Gooderham NJ, Njuguna J, Zhu HJ (2014) Assessment of temporal dose-toxicity relationship of fumed silica nanoparticle in human lung A549 cells by conventional cytotoxicity and H-1-NMR-based extracellular metabonomic assays. Toxicol Sci 138:354–364. doi: 10.1093/toxsci/kfu00910.1093/toxsci/kfu009 ↗
12. Kajita M, Hikosaka K, Iitsuka M, Kanayama A, Toshima N, Miyamoto Y (2007) Platinum nanoparticle is a useful scavenger of superoxide anion and hydrogen peroxide. Free Radic Res 41:615–626. doi: 10.1080/1071576060116967910.1080/10715760601169679 ↗
13. Kaul Z, Yaguchi T, Kaul SC, Wadhwa R (2006) Quantum dot-based protein imaging and functional significance of two mitochondrial chaperones in cellular senescence and carcinogenesis. In: Rattan S, Kristensen P, Clark BFC (eds) Understanding and Modulating Aging, vol 1067. Annals of the New York Academy of Sciences. Blackwell Publishing, Oxford, pp 469–473. doi: 10.1196/annals.1354.067
14. Khan MI, Mohammad A, Patil G, Naqvi SAH, Chauhan LKS, Ahmad I (2012) Induction of ROS, mitochondrial damage and autophagy in lung epithelial cancer cells by iron oxide nanoparticles. Biomaterials 33:1477–1488. doi: 10.1016/j.biomaterials.2011.10.08010.1016/j.biomaterials.2011.10.080 ↗
15. Lalande C et al (2011) Magnetic resonance imaging tracking of human adipose derived stromal cells within three-dimensional scaffolds for bone tissue engineering. Eur Cells Mater 21:341–35410.22203/eCM.v021a25 ↗
16. Laurent S, Forge D, Port M, Roch A, Robic C, Elst LV, Muller RN (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108:2064–2110. doi: 10.1021/cr068445e10.1021/cr068445e ↗
17. Lee JH et al (2011) Exchange-coupled magnetic nanoparticles for efficient heat induction. Nat Nanotechnol 6:418–422. doi: 10.1038/nnano.2011.9510.1038/nnano.2011.95 ↗
18. Li YF, Chen CY (2011) Fate and toxicity of metallic and metal-containing nanoparticles for biomedical applications. Small 7:2965–2980. doi: 10.1002/smll.20110105910.1002/smll.201101059 ↗
19. Li N et al (2003) Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect 111:455–460. doi: 10.1289/ehp.600010.1289/ehp.6000 ↗
20. Lunov O et al (2010) The effect of carboxydextran-coated superparamagnetic iron oxide nanoparticles on c-Jun N-terminal kinase-mediated apoptosis in human macrophages. Biomaterials 31:5063–5071. doi: 10.1016/j.biomaterials.2010.03.02310.1016/j.biomaterials.2010.03.023 ↗
21. Mahmoudi M, Simchi A, Imani M (2009) Cytotoxicity of uncoated and polyvinyl alcohol coated superparamagnetic iron oxide nanoparticles. J Phys Chem C 113:9573–9580. doi: 10.1021/jp900151610.1021/jp9001516 ↗
22. Mahmoudi M, Simchi A, Imani M, Shokrgozard MA, Milani AS, Hafeli UO, Stroeve P (2010) A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles. Colloid Surf B-Biointerfaces 75:300–309. doi: 10.1016/j.colsurfb.2009.08.04410.1016/j.colsurfb.2009.08.044 ↗
23. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G (2007) Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 8:741–752. doi: 10.1038/nrm223910.1038/nrm2239 ↗
24. Marano F, Hussain S, Rodrigues-Lima F, Baeza-Squiban A, Boland S (2011) Nanoparticles: molecular targets and cell signalling. Arch Toxicol 85:733–741. doi: 10.1007/s00204-010-0546-410.1007/s00204-010-0546-4 ↗
25. Nel A, Xia T, Madler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311:622–627. doi: 10.1126/science.111439710.1126/science.1114397 ↗
26. Nicco C, Laurent A, Chereau C, Weill B, Batteux F (2005) Differential modulation of normal and tumor cell proliferation by reactive oxygen species. Biomed Pharmacother 59:169–174. doi: 10.1016/j.biopha.2005.03.00910.1016/j.biopha.2005.03.009 ↗
27. Ostrowski AD, Martin T, Conti J, Hurt I, Harthorn BH (2009) Nanotoxicology: characterizing the scientific literature, 2000-2007. J Nanopart Res 11:251–257. doi: 10.1007/s11051-008-9579-510.1007/s11051-008-9579-5 ↗
28. Ozben T (2007) Oxidative stress and apoptosis: impact on cancer therapy. J Pharm Sci 96:2181–2196. doi: 10.1002/jps.2087410.1002/jps.20874 ↗
29. Pan Y et al (2007) Size-dependent cytotoxicity of gold nanoparticles. Small 3:1941–1949. doi: 10.1002/smll.20070037810.1002/smll.200700378 ↗
30. Paunesku T et al (2007) Intracellular distribution of TiO2-DNA oligonucleotide nanoconjugates directed to nucleolus and mitochondria indicates sequence specificity. Nano Lett 7:596–601. doi: 10.1021/nl062472310.1021/nl0624723 ↗
31. Qiu Y et al (2010) Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials 31:7606–7619. doi: 10.1016/j.biomaterials.2010.06.05110.1016/j.biomaterials.2010.06.051 ↗
32. Salnikov V, Lukyanenko YO, Frederick CA, Lederer WJ, Lukyanenko V (2007) Probing the outer mitochondrial membrane in cardiac mitochondria with nanoparticles. Biophys J 92:1058–1071. doi: 10.1529/biophysj.106.09431810.1529/biophysj.106.094318 ↗
33. Sharifi S, Behzadi S, Laurent S, Forrest ML, Stroeve P, Mahmoudi M (2012) Toxicity of nanomaterials. Chem Soc Rev 41:2323–2343. doi: 10.1039/c1cs15188f10.1039/C1CS15188F ↗
34. Shen CC, James SA, de Jonge MD, Turney TW, Wright PFA, Feltis BN (2013) Relating cytotoxicity, zinc ions, and reactive oxygen in zno nanoparticleexposed human immune cells. Toxicol Sci 136:120–130. doi: 10.1093/toxsci/kft18710.1093/toxsci/kft187 ↗
35. Soenen SJ, Rivera-Gil P, Montenegro JM, Parak WJ, De Smedt SC, Braeckmans K (2011) Cellular toxicity of inorganic nanoparticles: common aspects and guidelines for improved nanotoxicity evaluation. Nano Today 6:446–465. doi: 10.1016/j.nantod.2011.08.00110.1016/j.nantod.2011.08.001 ↗
36. Szeto HH (2006) Cell-permeable, mitochondrial-targeted, peptide antioxidants. AAPS J 8:E277–E28310.1007/BF02854898 ↗
37. Wahajuddin Arora S (2012) Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Int J Nanomed 7:3445–3471. doi: 10.2147/ijn.s3032010.2147/IJN.S30320 ↗
38. Wang J, Yi J (2008) Cancer cell killing via ROS To increase or decrease, that is the question. Cancer Biol Ther 7:1875–188410.4161/cbt.7.12.7067 ↗
39. Wu SYH, Tseng CL, Lin FH (2010) A newly developed Fe-doped calcium sulfide nanoparticles with magnetic property for cancer hyperthermia. J Nanopart Res 12:1173–1185. doi: 10.1007/s11051-009-9734-710.1007/s11051-009-9734-7 ↗
40. Yamada Y, Harashima H (2008) Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases. Adv Drug Deliv Rev 60:1439–1462. doi: 10.1016/j.addr.2008.04.01610.1016/j.addr.2008.04.016 ↗
41. Yamada Y et al (2008) MITO-Porter: a liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion. Biochim Biophys Acta-Biomembr 1778:423–432. doi: 10.1016/j.bbamem.2007.11.00210.1016/j.bbamem.2007.11.002 ↗